Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2021
∙
ATAGI
ATAGI Annual Statement on Immunisation 2021 - 24 May 2021
2021
∙
ATAGI
ATAGI clinical guidance on COVID-19 vaccine in Australia - 13 April, 2021
2021
∙
ATAGI
ATAGI Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines - 9 August 2021
2021
∙
ATAGI
ATAGI immunisation provider guide to obtaining informed consent for COVID-19 vaccine.
2021
∙
ATAGI
ATAGI statement on SARS-CoV-2 Omicron variant and COVID-19 booster doses
2021
∙
Conseil Supérieur de la Santé (CSS)
Belgian recommendation of an additional dose of COVID-19 mRNA vaccine (Part one)
2021
Booster dose after Janssen vaccine
2021
Booster dose for healthcare workers
2021
Booster vaccination against COVID-19
2021
∙
CCVS
booster vaccination against COVID-19 for people having received the complete primary series
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register